儿童原发性膜性肾病的临床与病理特征
该研究回顾性分析美国3个中心21例儿童原发性膜性肾病(PMN)的临床表现与结局,并在活检标本中检测新型抗原,另与Arkana实验室127例儿童PMN活检验证队列比较。两队列抗原阳性率相似(62%–63%),PLA2R和EXT1最常见;临床队列21例中17例达到完全或部分缓解,PLA2R或EXT1阳性者进入缓解的可能性显著高于抗原阴性组。
要点
- 儿童PMN中约60%活检可检出新型抗原,PLA2R和EXT1最常见。
- 临床队列21例中17例达到完全或部分缓解,总体肾脏预后良好。
- PLA2R或EXT1阳性儿童进入缓解的可能性显著高于抗原阴性组。
核心结论
- 约60%的儿童膜性病例肾活检新型抗原阳性,临床预后总体良好。
- 需要更多研究来理解每种特定新型抗原的临床意义。
研究设计与样本
- 回顾性分析美国3个中心21例儿童PMN的临床表现和结局数据。
- 在活检标本中鉴定新型抗原,并将抗原存在与否与临床结局相关联。
- 将临床队列的新型抗原染色结果与Arkana Laboratories 127例儿童PMN活检验证队列进行比较。
主要发现
- 两个队列总体抗原阳性率相似,为62%至63%,PLA2R和EXT1是最常见的抗原。
- 临床队列中21例儿童PMN患者有17例进入完全或部分缓解。
- PLA2R或EXT1阳性的儿童进入缓解的可能性显著高于抗原阴性组。
关键数值与推荐
- 两个队列总体抗原阳性率分别为62%至63%。
- 临床队列21例中17例达到完全或部分缓解。
临床怎么用
- 儿童PMN肾活检可检测新型抗原,PLA2R和EXT1为最常见抗原。
- PLA2R或EXT1阳性与更可能进入缓解相关,但各特定抗原的临床意义仍需更多研究。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Primary membranous nephropathy (PMN) is uncommon in children. Therefore, data on the clinical course of affected children are scarce. In recent years, several novel antigens have been implicated in the pathogenesis of PMN. However, the histopathologic characteristics of pediatric patients with PMN remain poorly represented in the literature. METHODS: We have retrospectively analyzed the clinical presentation and outcomes data of 21 children with PMN from 3 centers in the United States. In addition, we have identified novel antigens in biopsy specimens from these patients and correlated their presence or absence to clinical outcomes. Finally, we compared the results of the novel antigen staining from our clinical cohort to a validation cohort of 127 biopsy specimens from children with PMN at Arkana Laboratories. RESULTS: The data from the 2 cohorts demonstrated similar overall antigen positivity rates of 62% to 63%, with phospholipase A2 receptor (PLA2R) and exostosin 1 (EXT1) being the most commonly found antigens. Results from the clinical cohort showed that overall, the kidney prognosis for children with PMN was good, with 17 of 21 patients entering a complete or partial remission. Children who were positive for PLA2R or EXT1 were significantly more likely to enter remission than those in the antigen negative group. CONCLUSION: Approximately 60% of pediatric membranous cases are positive for a novel antigen on kidney biopsy and the clinical prognosis is generally favorable. More studies are needed to understand the clinical implications of each specific novel antigen.
引用
- Kouri AM, Caza TN, Beck LH, et al. Clinical and Histopathologic Characteristics of Pediatric Patients With Primary Membranous Nephropathy. Kidney Int Rep. 2023. PMID: 38025223. doi:10.1016/j.ekir.2023.08.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。